PCT LTD announces receipts of new purchase orders for annihilyzer infection control systems in NYC hospitals

April 14, 2020

LITTLE RIVER, SC -PCT LTD, through its operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announces two new purchase orders for PCT Corp.’s Annihilyzer® Infection Control Systems.

The installations will take place in two NYC hospitals with a combined bed count exceeding 700 and will be installed in coordination with PCT Corp’s primary healthcare distributor, ACE Janitorial Services.

“Receiving these purchase orders right now with everything going on in New York City is a testament to the growing demand for our systems and positive word of mouth recommendations we’ve received from our current clients and distributors,” says PCTL CEO Gary Grieco, adding that current travel restrictions in New York and the tri-state area have temporarily reduced the company’s ability to engage in installation efforts.

The company believes that once the current travel restrictions are lifted, they will be able to continue their plans for accelerated placements of Annihilyzer® systems in New York City and elsewhere. “We have a number of interested parties in our sales pipeline,” adds Grieco.

The company recently announced it had shifted its short-term focus towards fluid sales and distribution and is currently vetting and signing additional fluid distributors to fulfill the growing demand.

“We recently expanded our fluid production capacity to meet the current demand,” says PCT Corp President Bill Prince. “Even though we can now produce up to 10,000 gallons of fluids per day, the demand continues to increase. We are actively developing strategic partnerships for expanded distribution of our fluids.”

– BUSINESS WIRE

 

About PCT LTD:

PCT LTD (“PCTL”) focuses its business on acquiring, developing and providing sustainable, environmentally safe disinfecting, cleaning and tracking technologies. The company acquires and holds rights to innovative products and technologies, which are commercialized through its wholly-owned operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp). Currently trading on OTC, “PCTL” aspires to and is actively engaged in preparations for up-listing its common stock to a national securities exchange. The Company established entry into its target markets with commercially viable products in the United States and now continues to gain market share in the U.S. and U.K.